| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fatigue Syndrome, Chronic | 78 | 2023 | 214 | 10.540 |
Why?
|
| Herpesvirus 6, Human | 23 | 2021 | 95 | 4.890 |
Why?
|
| Roseolovirus Infections | 12 | 2021 | 45 | 4.230 |
Why?
|
| Herpesvirus 7, Human | 7 | 2018 | 12 | 2.030 |
Why?
|
| Herpesviridae Infections | 13 | 2019 | 277 | 1.120 |
Why?
|
| Fatigue | 18 | 2023 | 1531 | 0.790 |
Why?
|
| Virus Integration | 2 | 2021 | 299 | 0.750 |
Why?
|
| Research | 8 | 2019 | 1999 | 0.670 |
Why?
|
| Herpesviridae | 1 | 2019 | 109 | 0.670 |
Why?
|
| Protein Folding | 1 | 2021 | 840 | 0.620 |
Why?
|
| Fetal Growth Retardation | 1 | 2021 | 570 | 0.590 |
Why?
|
| Herpes Simplex | 1 | 2020 | 470 | 0.580 |
Why?
|
| Virus Replication | 6 | 2021 | 2535 | 0.560 |
Why?
|
| Immunocompromised Host | 2 | 2020 | 847 | 0.540 |
Why?
|
| Abortion, Spontaneous | 1 | 2021 | 544 | 0.530 |
Why?
|
| Biological Phenomena | 1 | 2015 | 28 | 0.530 |
Why?
|
| Congresses as Topic | 1 | 2019 | 764 | 0.500 |
Why?
|
| Protein Structure, Tertiary | 1 | 2021 | 3848 | 0.480 |
Why?
|
| Knowledge | 1 | 2015 | 181 | 0.470 |
Why?
|
| Gastrointestinal Tract | 1 | 2018 | 814 | 0.410 |
Why?
|
| RNA Interference | 3 | 2006 | 2891 | 0.410 |
Why?
|
| DNA, Viral | 10 | 2020 | 2227 | 0.390 |
Why?
|
| Pharyngitis | 10 | 1997 | 215 | 0.370 |
Why?
|
| Humans | 199 | 2023 | 744376 | 0.350 |
Why?
|
| Biomedical Research | 4 | 2017 | 3309 | 0.330 |
Why?
|
| Administrative Personnel | 1 | 2009 | 187 | 0.310 |
Why?
|
| Genetic Research | 2 | 2005 | 174 | 0.310 |
Why?
|
| Preventive Medicine | 1 | 2009 | 264 | 0.300 |
Why?
|
| Hematologic Diseases | 1 | 2010 | 498 | 0.280 |
Why?
|
| Central Nervous System Viral Diseases | 1 | 2006 | 39 | 0.280 |
Why?
|
| Molecular Biology | 2 | 2015 | 596 | 0.280 |
Why?
|
| Stilbenes | 1 | 2006 | 155 | 0.270 |
Why?
|
| Chlamydia Infections | 7 | 1992 | 365 | 0.260 |
Why?
|
| Sleep | 1 | 2021 | 4623 | 0.260 |
Why?
|
| Persian Gulf Syndrome | 1 | 2005 | 45 | 0.250 |
Why?
|
| Medical Record Linkage | 1 | 2006 | 284 | 0.250 |
Why?
|
| Diagnostic Tests, Routine | 4 | 2004 | 783 | 0.250 |
Why?
|
| Preventive Health Services | 3 | 2009 | 575 | 0.240 |
Why?
|
| Communicable Diseases | 2 | 2011 | 880 | 0.240 |
Why?
|
| Lymphocyte Subsets | 1 | 2005 | 315 | 0.240 |
Why?
|
| Facial Injuries | 1 | 2005 | 183 | 0.240 |
Why?
|
| Life Style | 2 | 2023 | 3835 | 0.240 |
Why?
|
| Central Nervous System Diseases | 4 | 2018 | 518 | 0.240 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2011 | 1534 | 0.230 |
Why?
|
| Urination Disorders | 7 | 1986 | 241 | 0.230 |
Why?
|
| History, 20th Century | 3 | 2021 | 2740 | 0.230 |
Why?
|
| Energy Metabolism | 3 | 2021 | 2897 | 0.220 |
Why?
|
| Multiple Sclerosis | 7 | 2020 | 3079 | 0.220 |
Why?
|
| Mental Healing | 1 | 2002 | 29 | 0.220 |
Why?
|
| Biology | 2 | 2023 | 295 | 0.220 |
Why?
|
| Occupational Health | 1 | 2009 | 808 | 0.220 |
Why?
|
| Genetics, Medical | 1 | 2005 | 338 | 0.220 |
Why?
|
| Family Practice | 2 | 2021 | 516 | 0.220 |
Why?
|
| Xenotropic murine leukemia virus-related virus | 2 | 2012 | 4 | 0.220 |
Why?
|
| Life Expectancy | 2 | 2005 | 1184 | 0.210 |
Why?
|
| Fibromyalgia | 4 | 1997 | 388 | 0.210 |
Why?
|
| Biomedical Technology | 1 | 2005 | 220 | 0.210 |
Why?
|
| Encephalitis, Viral | 2 | 2020 | 55 | 0.210 |
Why?
|
| Atherosclerosis | 1 | 2018 | 3444 | 0.210 |
Why?
|
| Placebo Effect | 2 | 2002 | 502 | 0.210 |
Why?
|
| Drug Hypersensitivity | 1 | 2010 | 884 | 0.200 |
Why?
|
| Complementary Therapies | 2 | 2002 | 486 | 0.200 |
Why?
|
| Encephalomyelitis | 1 | 2021 | 34 | 0.200 |
Why?
|
| Diagnosis | 2 | 2001 | 154 | 0.200 |
Why?
|
| Herpesvirus 2, Human | 2 | 2020 | 189 | 0.200 |
Why?
|
| Leukemia Virus, Murine | 2 | 2012 | 117 | 0.200 |
Why?
|
| Diffusion of Innovation | 1 | 2006 | 725 | 0.200 |
Why?
|
| Endoribonucleases | 2 | 2000 | 229 | 0.200 |
Why?
|
| Risk Reduction Behavior | 1 | 2008 | 1125 | 0.200 |
Why?
|
| tau Proteins | 2 | 2021 | 1868 | 0.190 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2006 | 587 | 0.190 |
Why?
|
| Nervous System Diseases | 1 | 2011 | 1622 | 0.190 |
Why?
|
| Depressive Disorder, Major | 2 | 2011 | 4644 | 0.190 |
Why?
|
| Neuritis | 1 | 2020 | 36 | 0.190 |
Why?
|
| Sick Role | 1 | 2001 | 237 | 0.190 |
Why?
|
| Antibodies, Viral | 13 | 2011 | 3177 | 0.180 |
Why?
|
| Organ Transplantation | 1 | 2010 | 1140 | 0.180 |
Why?
|
| Skin Transplantation | 1 | 2005 | 1074 | 0.180 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2006 | 1205 | 0.180 |
Why?
|
| Physician-Patient Relations | 4 | 2021 | 3229 | 0.180 |
Why?
|
| Genomics | 2 | 2006 | 5717 | 0.180 |
Why?
|
| Acute-Phase Reaction | 1 | 1999 | 91 | 0.180 |
Why?
|
| Quebec | 1 | 2019 | 134 | 0.180 |
Why?
|
| Seizures, Febrile | 1 | 2020 | 111 | 0.170 |
Why?
|
| United States | 33 | 2016 | 69869 | 0.170 |
Why?
|
| Alzheimer Disease | 1 | 2020 | 8038 | 0.170 |
Why?
|
| Infectious Mononucleosis | 4 | 1988 | 131 | 0.170 |
Why?
|
| Cytokines | 3 | 2018 | 7323 | 0.170 |
Why?
|
| Longevity | 1 | 2006 | 1071 | 0.170 |
Why?
|
| Epilepsy, Temporal Lobe | 2 | 2020 | 403 | 0.160 |
Why?
|
| Berlin | 1 | 2018 | 23 | 0.160 |
Why?
|
| Cerebrospinal Fluid | 1 | 2021 | 535 | 0.160 |
Why?
|
| Health Behavior | 2 | 2007 | 2635 | 0.160 |
Why?
|
| Animals | 15 | 2021 | 168770 | 0.150 |
Why?
|
| Amyloid beta-Peptides | 2 | 2021 | 3587 | 0.150 |
Why?
|
| Nervous System | 1 | 2021 | 554 | 0.150 |
Why?
|
| Inflammation | 1 | 2017 | 10636 | 0.150 |
Why?
|
| Neutrophil Activation | 1 | 1998 | 186 | 0.150 |
Why?
|
| Menstruation Disturbances | 1 | 1998 | 148 | 0.150 |
Why?
|
| Urinary Tract Infections | 11 | 1986 | 788 | 0.150 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2004 | 1203 | 0.150 |
Why?
|
| Methylamines | 1 | 2018 | 123 | 0.150 |
Why?
|
| Herpesvirus 1, Human | 2 | 2020 | 743 | 0.150 |
Why?
|
| Female | 84 | 2023 | 380200 | 0.150 |
Why?
|
| Metagenomics | 2 | 2018 | 428 | 0.150 |
Why?
|
| Metabolomics | 3 | 2023 | 1485 | 0.150 |
Why?
|
| Cervix Uteri | 1 | 2021 | 590 | 0.150 |
Why?
|
| Exercise | 4 | 2008 | 5615 | 0.140 |
Why?
|
| Bacteroidetes | 1 | 2017 | 83 | 0.140 |
Why?
|
| Anastomosis, Roux-en-Y | 1 | 2017 | 87 | 0.140 |
Why?
|
| Brain | 5 | 2021 | 26386 | 0.140 |
Why?
|
| Germ-Free Life | 1 | 2017 | 188 | 0.140 |
Why?
|
| Hospitals, Teaching | 5 | 1997 | 1180 | 0.140 |
Why?
|
| Physical Examination | 7 | 2009 | 1237 | 0.140 |
Why?
|
| Health Status Disparities | 1 | 2008 | 1796 | 0.140 |
Why?
|
| Exanthema Subitum | 3 | 2010 | 4 | 0.140 |
Why?
|
| Immunoglobulin Isotypes | 1 | 1996 | 158 | 0.140 |
Why?
|
| Diagnosis, Differential | 16 | 2011 | 12961 | 0.140 |
Why?
|
| Information Systems | 4 | 1999 | 410 | 0.140 |
Why?
|
| Sialoglycoproteins | 1 | 1997 | 318 | 0.140 |
Why?
|
| Receptors, Interleukin-1 | 1 | 1997 | 262 | 0.140 |
Why?
|
| Case-Control Studies | 11 | 2022 | 21747 | 0.140 |
Why?
|
| Electroencephalography | 1 | 2011 | 6150 | 0.140 |
Why?
|
| Health Promotion | 1 | 2008 | 2205 | 0.140 |
Why?
|
| Obesity | 2 | 2017 | 12745 | 0.130 |
Why?
|
| Physiological Phenomena | 1 | 2015 | 18 | 0.130 |
Why?
|
| Herpesvirus 4, Human | 9 | 1998 | 1041 | 0.130 |
Why?
|
| Antiviral Agents | 4 | 2010 | 2987 | 0.130 |
Why?
|
| Stem Cells | 1 | 2008 | 3567 | 0.130 |
Why?
|
| History, 21st Century | 1 | 2021 | 1534 | 0.130 |
Why?
|
| Germ Cells | 2 | 2017 | 631 | 0.130 |
Why?
|
| Adult | 64 | 2021 | 214056 | 0.130 |
Why?
|
| Liver Extracts | 1 | 1994 | 6 | 0.130 |
Why?
|
| Poly U | 1 | 1994 | 10 | 0.130 |
Why?
|
| Apolipoproteins E | 1 | 2020 | 1438 | 0.120 |
Why?
|
| Parvovirus B19, Human | 2 | 2009 | 38 | 0.120 |
Why?
|
| Sleep Deprivation | 1 | 2021 | 832 | 0.120 |
Why?
|
| Mycoplasma fermentans | 1 | 1993 | 9 | 0.120 |
Why?
|
| Burns | 1 | 2005 | 1815 | 0.120 |
Why?
|
| Poly I-C | 1 | 1994 | 115 | 0.120 |
Why?
|
| Hormones | 1 | 1998 | 889 | 0.120 |
Why?
|
| Computer Communication Networks | 1 | 1996 | 295 | 0.120 |
Why?
|
| Stress, Physiological | 2 | 1999 | 1403 | 0.120 |
Why?
|
| Vaginal Diseases | 5 | 1980 | 102 | 0.120 |
Why?
|
| Professional Practice | 1 | 1996 | 326 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2017 | 11725 | 0.120 |
Why?
|
| Motivation | 1 | 2023 | 1971 | 0.110 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2003 | 1186 | 0.110 |
Why?
|
| Pregnancy Outcome | 1 | 2004 | 2795 | 0.110 |
Why?
|
| Protein Conformation | 1 | 2021 | 4010 | 0.110 |
Why?
|
| Interleukin-1 | 1 | 1997 | 1263 | 0.110 |
Why?
|
| Thinness | 1 | 2017 | 480 | 0.110 |
Why?
|
| Clinical Laboratory Techniques | 5 | 1999 | 738 | 0.110 |
Why?
|
| Brain Diseases | 2 | 2020 | 1563 | 0.110 |
Why?
|
| Antibodies, Bacterial | 4 | 1993 | 1470 | 0.110 |
Why?
|
| Healthcare Disparities | 1 | 2008 | 3154 | 0.110 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2010 | 5445 | 0.110 |
Why?
|
| Bacteria | 4 | 2023 | 2115 | 0.110 |
Why?
|
| Chlamydia trachomatis | 5 | 1989 | 246 | 0.110 |
Why?
|
| Central Nervous System | 1 | 2000 | 1357 | 0.110 |
Why?
|
| Spumavirus | 1 | 1992 | 16 | 0.110 |
Why?
|
| Costs and Cost Analysis | 9 | 1992 | 1680 | 0.100 |
Why?
|
| Chlamydophila pneumoniae | 1 | 1992 | 55 | 0.100 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 1994 | 362 | 0.100 |
Why?
|
| Autonomic Nervous System | 1 | 1997 | 671 | 0.100 |
Why?
|
| Endogenous Retroviruses | 1 | 2013 | 112 | 0.100 |
Why?
|
| Placenta | 1 | 2021 | 1699 | 0.100 |
Why?
|
| Self Report | 1 | 2023 | 3557 | 0.100 |
Why?
|
| Mass Screening | 2 | 2004 | 5255 | 0.100 |
Why?
|
| Male | 62 | 2020 | 350118 | 0.100 |
Why?
|
| Blood | 2 | 2011 | 598 | 0.100 |
Why?
|
| Vaginitis | 8 | 1986 | 47 | 0.100 |
Why?
|
| Urethritis | 4 | 1986 | 23 | 0.100 |
Why?
|
| Physicians | 4 | 2007 | 4567 | 0.100 |
Why?
|
| Myocardial Infarction | 6 | 2004 | 11718 | 0.090 |
Why?
|
| Virus Diseases | 4 | 1997 | 711 | 0.090 |
Why?
|
| Chronic Disease | 14 | 2009 | 9145 | 0.090 |
Why?
|
| Risk Factors | 8 | 2023 | 72295 | 0.090 |
Why?
|
| Ambulatory Care | 8 | 1999 | 2708 | 0.090 |
Why?
|
| Proteome | 1 | 2020 | 1798 | 0.090 |
Why?
|
| Polysaccharides | 1 | 2017 | 1059 | 0.090 |
Why?
|
| Depressive Disorder | 6 | 2001 | 3748 | 0.090 |
Why?
|
| Streptococcal Infections | 4 | 1997 | 638 | 0.090 |
Why?
|
| Patient Care Planning | 5 | 1982 | 921 | 0.090 |
Why?
|
| Diagnostic Services | 1 | 1989 | 34 | 0.090 |
Why?
|
| Physician Assistants | 5 | 1978 | 192 | 0.090 |
Why?
|
| Pregnancy Complications | 1 | 2004 | 2861 | 0.090 |
Why?
|
| Evaluation Studies as Topic | 9 | 1990 | 1681 | 0.090 |
Why?
|
| Viral Proteins | 2 | 2013 | 1900 | 0.080 |
Why?
|
| Antibodies | 2 | 2002 | 2460 | 0.080 |
Why?
|
| Transforming Growth Factor beta | 1 | 1997 | 2007 | 0.080 |
Why?
|
| Cost-Benefit Analysis | 13 | 1994 | 5390 | 0.080 |
Why?
|
| Pain | 5 | 2018 | 4987 | 0.080 |
Why?
|
| Nursing Homes | 2 | 1987 | 1036 | 0.080 |
Why?
|
| Energy Intake | 1 | 2017 | 2148 | 0.080 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 1997 | 2015 | 0.080 |
Why?
|
| Dysgammaglobulinemia | 1 | 1988 | 21 | 0.080 |
Why?
|
| B-Lymphocytes | 2 | 2020 | 4666 | 0.080 |
Why?
|
| IgG Deficiency | 1 | 1988 | 28 | 0.080 |
Why?
|
| Patient Satisfaction | 1 | 2001 | 3395 | 0.080 |
Why?
|
| Middle Aged | 40 | 2020 | 213388 | 0.080 |
Why?
|
| Pyuria | 3 | 1986 | 30 | 0.080 |
Why?
|
| Artificial Intelligence | 1 | 2021 | 2213 | 0.080 |
Why?
|
| Syndrome | 8 | 1989 | 3252 | 0.080 |
Why?
|
| Principal Component Analysis | 1 | 2011 | 940 | 0.080 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2009 | 241 | 0.080 |
Why?
|
| Virus Latency | 2 | 2010 | 358 | 0.080 |
Why?
|
| Disease Progression | 1 | 2005 | 13285 | 0.080 |
Why?
|
| Decision Making | 6 | 2004 | 3888 | 0.080 |
Why?
|
| Polymyalgia Rheumatica | 1 | 1988 | 54 | 0.080 |
Why?
|
| Chromosomes, Human | 1 | 2010 | 457 | 0.080 |
Why?
|
| Medical Audit | 4 | 1986 | 467 | 0.080 |
Why?
|
| Aging | 1 | 2006 | 8663 | 0.080 |
Why?
|
| MicroRNAs | 1 | 2003 | 3751 | 0.080 |
Why?
|
| Autoanalysis | 1 | 1987 | 72 | 0.080 |
Why?
|
| Urine | 3 | 1986 | 370 | 0.080 |
Why?
|
| Terminology as Topic | 3 | 1996 | 1547 | 0.080 |
Why?
|
| Proto-Oncogenes | 1 | 2008 | 321 | 0.080 |
Why?
|
| Disease | 2 | 1990 | 680 | 0.070 |
Why?
|
| Laboratories, Hospital | 2 | 1997 | 194 | 0.070 |
Why?
|
| Antigens, Viral | 4 | 2010 | 1035 | 0.070 |
Why?
|
| Management Information Systems | 1 | 1987 | 50 | 0.070 |
Why?
|
| Disease Management | 1 | 2018 | 2460 | 0.070 |
Why?
|
| Forecasting | 1 | 1996 | 2951 | 0.070 |
Why?
|
| Neurosciences | 1 | 2011 | 348 | 0.070 |
Why?
|
| DNA | 2 | 2015 | 7294 | 0.070 |
Why?
|
| Boston | 11 | 1999 | 9312 | 0.070 |
Why?
|
| Wine | 1 | 2006 | 165 | 0.070 |
Why?
|
| Clinical Laboratory Information Systems | 1 | 1987 | 108 | 0.070 |
Why?
|
| Medical History Taking | 6 | 1993 | 784 | 0.070 |
Why?
|
| Blood Grouping and Crossmatching | 1 | 1986 | 108 | 0.070 |
Why?
|
| Population Growth | 1 | 2005 | 52 | 0.070 |
Why?
|
| Comprehension | 1 | 2011 | 610 | 0.070 |
Why?
|
| Aviation | 1 | 2005 | 42 | 0.070 |
Why?
|
| Gulf War | 1 | 2005 | 29 | 0.070 |
Why?
|
| Pharmacy Service, Hospital | 1 | 2006 | 133 | 0.070 |
Why?
|
| Petunia | 1 | 2005 | 1 | 0.070 |
Why?
|
| Arthralgia | 1 | 2009 | 456 | 0.070 |
Why?
|
| Therapeutic Touch | 1 | 2005 | 8 | 0.070 |
Why?
|
| Weight Loss | 1 | 2017 | 2625 | 0.060 |
Why?
|
| Human Genome Project | 1 | 2005 | 193 | 0.060 |
Why?
|
| World War II | 1 | 2005 | 59 | 0.060 |
Why?
|
| Hospital Information Systems | 1 | 1988 | 395 | 0.060 |
Why?
|
| Prostatic Neoplasms | 1 | 2008 | 11126 | 0.060 |
Why?
|
| Hospital Records | 1 | 1985 | 95 | 0.060 |
Why?
|
| Back Pain | 2 | 1982 | 545 | 0.060 |
Why?
|
| Explosions | 1 | 2005 | 109 | 0.060 |
Why?
|
| Hospital Departments | 1 | 1985 | 137 | 0.060 |
Why?
|
| Technology, Radiologic | 1 | 1985 | 163 | 0.060 |
Why?
|
| Morbidity | 1 | 1990 | 1768 | 0.060 |
Why?
|
| Health Status | 2 | 1996 | 4033 | 0.060 |
Why?
|
| Primary Health Care | 7 | 1993 | 4557 | 0.060 |
Why?
|
| beta 2-Glycoprotein I | 1 | 2004 | 28 | 0.060 |
Why?
|
| Antibodies, Anticardiolipin | 1 | 2004 | 62 | 0.060 |
Why?
|
| Serum Amyloid A Protein | 1 | 2004 | 121 | 0.060 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2005 | 246 | 0.060 |
Why?
|
| Washington | 2 | 1995 | 313 | 0.060 |
Why?
|
| Pregnancy | 3 | 2021 | 29144 | 0.060 |
Why?
|
| Telomere | 1 | 2010 | 910 | 0.060 |
Why?
|
| Sprains and Strains | 1 | 1984 | 78 | 0.060 |
Why?
|
| Prothrombin | 1 | 2004 | 185 | 0.060 |
Why?
|
| Professional Review Organizations | 2 | 1985 | 50 | 0.060 |
Why?
|
| Killer Cells, Natural | 3 | 2005 | 2133 | 0.060 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2008 | 1097 | 0.060 |
Why?
|
| Physical Exertion | 2 | 1997 | 695 | 0.060 |
Why?
|
| Gonorrhea | 4 | 1984 | 335 | 0.060 |
Why?
|
| Radiology Department, Hospital | 2 | 1997 | 412 | 0.060 |
Why?
|
| Lymphocyte Count | 1 | 2005 | 793 | 0.060 |
Why?
|
| Prevalence | 4 | 2023 | 15221 | 0.050 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2004 | 281 | 0.050 |
Why?
|
| Urethral Diseases | 2 | 1980 | 53 | 0.050 |
Why?
|
| Epidemiologic Methods | 1 | 1988 | 1364 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 1998 | 3873 | 0.050 |
Why?
|
| Health Services for the Aged | 1 | 1985 | 269 | 0.050 |
Why?
|
| Butyrates | 1 | 2023 | 163 | 0.050 |
Why?
|
| Mood Disorders | 1 | 1989 | 1106 | 0.050 |
Why?
|
| Genome, Human | 1 | 2015 | 4420 | 0.050 |
Why?
|
| Nurses | 3 | 1977 | 2462 | 0.050 |
Why?
|
| Risk | 8 | 1998 | 9688 | 0.050 |
Why?
|
| Peptides | 1 | 1994 | 4410 | 0.050 |
Why?
|
| Protoporphyrins | 1 | 1982 | 164 | 0.050 |
Why?
|
| Lead Poisoning | 2 | 1982 | 301 | 0.050 |
Why?
|
| Neoplasms | 2 | 2008 | 21693 | 0.050 |
Why?
|
| Hospital Bed Capacity, 500 and over | 3 | 1997 | 115 | 0.050 |
Why?
|
| Feces | 2 | 2018 | 1401 | 0.050 |
Why?
|
| Pyelonephritis | 3 | 1987 | 75 | 0.050 |
Why?
|
| Virus Activation | 4 | 2010 | 319 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 5 | 2011 | 6171 | 0.050 |
Why?
|
| Immunophenotyping | 2 | 1999 | 1880 | 0.050 |
Why?
|
| Quality Assurance, Health Care | 2 | 1985 | 2212 | 0.050 |
Why?
|
| Cell Line | 7 | 2011 | 16000 | 0.050 |
Why?
|
| Emergencies | 1 | 1987 | 1170 | 0.050 |
Why?
|
| Medication Systems, Hospital | 1 | 2001 | 158 | 0.050 |
Why?
|
| Headache | 5 | 1996 | 1226 | 0.050 |
Why?
|
| Vitamin B 12 | 1 | 2004 | 527 | 0.050 |
Why?
|
| Nurse Practitioners | 4 | 1978 | 269 | 0.050 |
Why?
|
| Maternal Age | 1 | 2004 | 802 | 0.050 |
Why?
|
| Dyspepsia | 1 | 1982 | 116 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2008 | 20823 | 0.050 |
Why?
|
| Parity | 1 | 2004 | 929 | 0.050 |
Why?
|
| Salivary Glands, Minor | 1 | 2000 | 27 | 0.050 |
Why?
|
| Homocysteine | 1 | 2004 | 647 | 0.050 |
Why?
|
| Australia | 2 | 1994 | 1167 | 0.050 |
Why?
|
| Muscles | 3 | 1991 | 1614 | 0.050 |
Why?
|
| Quality of Health Care | 12 | 1987 | 4369 | 0.050 |
Why?
|
| Hysterectomy | 1 | 1986 | 927 | 0.050 |
Why?
|
| Clinical Enzyme Tests | 1 | 2000 | 115 | 0.050 |
Why?
|
| Acne Vulgaris | 1 | 1984 | 302 | 0.050 |
Why?
|
| Gene Targeting | 1 | 2003 | 880 | 0.050 |
Why?
|
| Dietary Fats | 1 | 2008 | 2016 | 0.050 |
Why?
|
| Porphyrins | 1 | 1982 | 348 | 0.050 |
Why?
|
| Trichomonas Vaginitis | 2 | 1978 | 35 | 0.040 |
Why?
|
| alpha-Macroglobulins | 1 | 1999 | 64 | 0.040 |
Why?
|
| Nanotechnology | 1 | 2005 | 710 | 0.040 |
Why?
|
| Neurons | 2 | 2006 | 9340 | 0.040 |
Why?
|
| Mice | 3 | 2017 | 81202 | 0.040 |
Why?
|
| Retroviridae Infections | 2 | 2011 | 151 | 0.040 |
Why?
|
| Infant | 3 | 2020 | 35134 | 0.040 |
Why?
|
| Stem Cell Transplantation | 1 | 2008 | 1620 | 0.040 |
Why?
|
| Blood Transfusion | 1 | 1986 | 1301 | 0.040 |
Why?
|
| Respiratory Tract Infections | 3 | 1978 | 961 | 0.040 |
Why?
|
| Face | 1 | 2005 | 994 | 0.040 |
Why?
|
| Ankle Injuries | 1 | 1984 | 331 | 0.040 |
Why?
|
| Concurrent Review | 1 | 1979 | 13 | 0.040 |
Why?
|
| Chi-Square Distribution | 2 | 2004 | 3508 | 0.040 |
Why?
|
| Child | 10 | 2020 | 77708 | 0.040 |
Why?
|
| Computers | 2 | 1999 | 612 | 0.040 |
Why?
|
| Stress, Psychological | 4 | 1999 | 4244 | 0.040 |
Why?
|
| Pharyngeal Diseases | 1 | 1980 | 133 | 0.040 |
Why?
|
| Acute Disease | 7 | 1993 | 7147 | 0.040 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2002 | 780 | 0.040 |
Why?
|
| Delivery, Obstetric | 1 | 1986 | 906 | 0.040 |
Why?
|
| Psychological Tests | 2 | 1993 | 651 | 0.040 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2002 | 337 | 0.040 |
Why?
|
| Massachusetts | 7 | 2004 | 8662 | 0.040 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 2 | 1994 | 1107 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 18034 | 0.040 |
Why?
|
| Telemedicine | 1 | 1996 | 2872 | 0.040 |
Why?
|
| Smoking | 3 | 2004 | 8987 | 0.040 |
Why?
|
| Factor V | 1 | 1999 | 178 | 0.040 |
Why?
|
| Serologic Tests | 4 | 1994 | 374 | 0.040 |
Why?
|
| Referral and Consultation | 4 | 1999 | 3529 | 0.040 |
Why?
|
| Placebos | 1 | 2002 | 1676 | 0.040 |
Why?
|
| Iatrogenic Disease | 2 | 1994 | 547 | 0.040 |
Why?
|
| Hospital-Physician Joint Ventures | 1 | 1998 | 30 | 0.040 |
Why?
|
| Cholesterol | 1 | 1987 | 2919 | 0.040 |
Why?
|
| Heart Diseases | 2 | 2004 | 2789 | 0.040 |
Why?
|
| Ambulatory Care Information Systems | 1 | 1998 | 86 | 0.040 |
Why?
|
| Cesarean Section | 1 | 1986 | 1365 | 0.040 |
Why?
|
| Prospective Studies | 15 | 1999 | 53291 | 0.040 |
Why?
|
| Utilization Review | 1 | 1979 | 392 | 0.040 |
Why?
|
| Organization and Administration | 2 | 1974 | 52 | 0.040 |
Why?
|
| Tilt-Table Test | 1 | 1997 | 78 | 0.040 |
Why?
|
| Rubella virus | 1 | 1996 | 11 | 0.040 |
Why?
|
| Data Display | 1 | 1997 | 182 | 0.040 |
Why?
|
| Valsalva Maneuver | 1 | 1997 | 92 | 0.040 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2005 | 1837 | 0.040 |
Why?
|
| Fever | 4 | 1988 | 1616 | 0.040 |
Why?
|
| Erythromycin | 1 | 1997 | 120 | 0.040 |
Why?
|
| Overweight | 1 | 2008 | 2371 | 0.040 |
Why?
|
| Aged | 19 | 2017 | 163284 | 0.040 |
Why?
|
| Lead | 1 | 1982 | 852 | 0.040 |
Why?
|
| False Positive Reactions | 3 | 2011 | 980 | 0.040 |
Why?
|
| Respiratory Tract Diseases | 1 | 1982 | 722 | 0.040 |
Why?
|
| Office Visits | 1 | 2001 | 598 | 0.040 |
Why?
|
| Enterovirus B, Human | 1 | 1996 | 52 | 0.040 |
Why?
|
| Lymphocytes | 3 | 2000 | 2617 | 0.030 |
Why?
|
| Body Temperature | 1 | 1999 | 777 | 0.030 |
Why?
|
| Complement Activation | 1 | 1998 | 453 | 0.030 |
Why?
|
| Pilot Projects | 4 | 2000 | 8319 | 0.030 |
Why?
|
| Radioimmunoassay | 1 | 1997 | 919 | 0.030 |
Why?
|
| Interferons | 1 | 2000 | 706 | 0.030 |
Why?
|
| Viral Core Proteins | 1 | 1996 | 162 | 0.030 |
Why?
|
| Menopause | 1 | 2004 | 1626 | 0.030 |
Why?
|
| Time and Motion Studies | 2 | 1987 | 149 | 0.030 |
Why?
|
| Chest Pain | 2 | 1994 | 1114 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2004 | 4933 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2021 | 2184 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2004 | 2266 | 0.030 |
Why?
|
| Immunoglobulin E | 1 | 2002 | 1463 | 0.030 |
Why?
|
| Renal Insufficiency | 1 | 2001 | 804 | 0.030 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 1997 | 297 | 0.030 |
Why?
|
| Hospital Charges | 1 | 1997 | 362 | 0.030 |
Why?
|
| Health Maintenance Organizations | 2 | 1978 | 642 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2006 | 2725 | 0.030 |
Why?
|
| Posture | 2 | 1997 | 958 | 0.030 |
Why?
|
| Solubility | 1 | 1997 | 1088 | 0.030 |
Why?
|
| Anorexia | 1 | 1996 | 161 | 0.030 |
Why?
|
| Leukorrhea | 1 | 1974 | 4 | 0.030 |
Why?
|
| Outpatient Clinics, Hospital | 2 | 1994 | 392 | 0.030 |
Why?
|
| Unnecessary Procedures | 1 | 1999 | 432 | 0.030 |
Why?
|
| Bartonella | 1 | 1994 | 12 | 0.030 |
Why?
|
| Metronidazole | 1 | 1976 | 217 | 0.030 |
Why?
|
| Borrelia burgdorferi Group | 1 | 1995 | 97 | 0.030 |
Why?
|
| Bartonella henselae | 1 | 1994 | 16 | 0.030 |
Why?
|
| Diagnostic Imaging | 1 | 2009 | 3508 | 0.030 |
Why?
|
| Cat-Scratch Disease | 1 | 1994 | 23 | 0.030 |
Why?
|
| Menstrual Cycle | 1 | 1998 | 551 | 0.030 |
Why?
|
| Length of Stay | 5 | 2001 | 6311 | 0.030 |
Why?
|
| Adenoviruses, Human | 1 | 1996 | 257 | 0.030 |
Why?
|
| Vestibular Function Tests | 1 | 1995 | 127 | 0.030 |
Why?
|
| Tachycardia | 1 | 1997 | 619 | 0.030 |
Why?
|
| Allergens | 1 | 2002 | 1320 | 0.030 |
Why?
|
| Women's Health | 1 | 2004 | 2034 | 0.030 |
Why?
|
| Sex Factors | 3 | 1999 | 10400 | 0.030 |
Why?
|
| Gonadal Steroid Hormones | 1 | 1998 | 711 | 0.030 |
Why?
|
| Dizziness | 1 | 1997 | 251 | 0.030 |
Why?
|
| Cognition Disorders | 2 | 2001 | 4043 | 0.030 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 1994 | 112 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 1997 | 977 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2022 | 2308 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2020 | 1157 | 0.030 |
Why?
|
| Cell Count | 1 | 1998 | 1856 | 0.030 |
Why?
|
| T-Lymphocytes | 5 | 1998 | 10183 | 0.030 |
Why?
|
| Decision Making, Computer-Assisted | 1 | 1994 | 150 | 0.030 |
Why?
|
| Single-Blind Method | 2 | 2012 | 1591 | 0.030 |
Why?
|
| Progesterone | 1 | 1998 | 775 | 0.030 |
Why?
|
| Hospital Units | 1 | 1994 | 141 | 0.030 |
Why?
|
| Reproduction | 1 | 1998 | 668 | 0.030 |
Why?
|
| Probability | 3 | 1986 | 2506 | 0.030 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 1998 | 703 | 0.030 |
Why?
|
| Borna disease virus | 1 | 1992 | 2 | 0.030 |
Why?
|
| Drug Therapy | 1 | 1976 | 497 | 0.030 |
Why?
|
| Pharmaceutical Preparations | 1 | 2001 | 1070 | 0.030 |
Why?
|
| Coronary Care Units | 1 | 1994 | 214 | 0.030 |
Why?
|
| AIDS Dementia Complex | 1 | 1994 | 154 | 0.030 |
Why?
|
| Medicine | 1 | 1982 | 946 | 0.030 |
Why?
|
| Superantigens | 1 | 2013 | 129 | 0.030 |
Why?
|
| RNA, Double-Stranded | 1 | 1994 | 290 | 0.030 |
Why?
|
| Nausea | 1 | 1996 | 674 | 0.030 |
Why?
|
| Predictive Value of Tests | 3 | 2004 | 15078 | 0.030 |
Why?
|
| Creatinine | 1 | 1998 | 1919 | 0.030 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2018 | 445 | 0.030 |
Why?
|
| Community Health Centers | 1 | 1976 | 430 | 0.030 |
Why?
|
| Hospitalization | 4 | 1988 | 10259 | 0.030 |
Why?
|
| Vestibule, Labyrinth | 1 | 1995 | 235 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2017 | 783 | 0.030 |
Why?
|
| Immunoglobulin G | 3 | 1996 | 4561 | 0.030 |
Why?
|
| Guidelines as Topic | 1 | 1999 | 1405 | 0.030 |
Why?
|
| Pneumonia | 2 | 1981 | 2133 | 0.030 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2001 | 1164 | 0.030 |
Why?
|
| Practice Management, Medical | 1 | 1974 | 196 | 0.030 |
Why?
|
| Financing, Government | 1 | 1976 | 468 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2000 | 3001 | 0.030 |
Why?
|
| Viremia | 2 | 2011 | 736 | 0.030 |
Why?
|
| CD4-CD8 Ratio | 1 | 1992 | 112 | 0.030 |
Why?
|
| Culture Media | 1 | 1994 | 909 | 0.030 |
Why?
|
| Patient Compliance | 2 | 1987 | 2685 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2004 | 3778 | 0.030 |
Why?
|
| Delivery of Health Care | 3 | 2005 | 5321 | 0.030 |
Why?
|
| Vestibular Diseases | 1 | 1995 | 217 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 1999 | 2216 | 0.030 |
Why?
|
| Immune System | 1 | 1997 | 806 | 0.030 |
Why?
|
| Child Health Services | 2 | 1976 | 667 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 10943 | 0.030 |
Why?
|
| Prognosis | 3 | 2020 | 29060 | 0.030 |
Why?
|
| Education, Medical | 3 | 2016 | 1722 | 0.030 |
Why?
|
| Veterans | 1 | 2005 | 2519 | 0.020 |
Why?
|
| Activities of Daily Living | 2 | 1996 | 2418 | 0.020 |
Why?
|
| Human T-lymphotropic virus 1 | 1 | 1992 | 140 | 0.020 |
Why?
|
| Muscular Diseases | 1 | 1996 | 555 | 0.020 |
Why?
|
| Hypertension | 3 | 1996 | 8479 | 0.020 |
Why?
|
| Statistics, Nonparametric | 2 | 2013 | 2887 | 0.020 |
Why?
|
| Double-Blind Method | 2 | 2002 | 12025 | 0.020 |
Why?
|
| Regional Medical Programs | 1 | 1971 | 71 | 0.020 |
Why?
|
| Community Health Services | 1 | 1976 | 650 | 0.020 |
Why?
|
| Risk Management | 1 | 1994 | 571 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 1995 | 1537 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2002 | 3610 | 0.020 |
Why?
|
| Allied Health Personnel | 3 | 1978 | 162 | 0.020 |
Why?
|
| Biometry | 1 | 1994 | 558 | 0.020 |
Why?
|
| Maternal Health Services | 1 | 1976 | 455 | 0.020 |
Why?
|
| Kidney Transplantation | 1 | 2005 | 4251 | 0.020 |
Why?
|
| Health Services Research | 2 | 1990 | 1836 | 0.020 |
Why?
|
| Hydrocortisone | 1 | 1998 | 1826 | 0.020 |
Why?
|
| Anti-Infective Agents, Urinary | 2 | 1984 | 28 | 0.020 |
Why?
|
| Cost Control | 2 | 1986 | 624 | 0.020 |
Why?
|
| GA-Binding Protein Transcription Factor | 1 | 2009 | 46 | 0.020 |
Why?
|
| Blood Specimen Collection | 1 | 2011 | 246 | 0.020 |
Why?
|
| Chlamydia | 1 | 1989 | 33 | 0.020 |
Why?
|
| Attitude of Health Personnel | 2 | 2021 | 3842 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 1995 | 970 | 0.020 |
Why?
|
| Phylogeny | 1 | 2017 | 2804 | 0.020 |
Why?
|
| Time Factors | 6 | 1996 | 40077 | 0.020 |
Why?
|
| Candidiasis, Vulvovaginal | 3 | 1979 | 25 | 0.020 |
Why?
|
| Genes, Viral | 1 | 2010 | 718 | 0.020 |
Why?
|
| Lyme Disease | 1 | 1995 | 621 | 0.020 |
Why?
|
| Radiography | 4 | 1987 | 7023 | 0.020 |
Why?
|
| Diet | 1 | 1987 | 7937 | 0.020 |
Why?
|
| Mental Disorders | 3 | 1998 | 6600 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2003 | 13035 | 0.020 |
Why?
|
| Cytomegalovirus | 1 | 1992 | 733 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 4 | 1997 | 7182 | 0.020 |
Why?
|
| Adolescent | 14 | 1991 | 85784 | 0.020 |
Why?
|
| Enterovirus Infections | 1 | 1988 | 72 | 0.020 |
Why?
|
| Laboratories | 1 | 2011 | 463 | 0.020 |
Why?
|
| Angina Pectoris | 1 | 1992 | 977 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2011 | 1341 | 0.020 |
Why?
|
| Diagnosis-Related Groups | 2 | 1989 | 455 | 0.020 |
Why?
|
| Bacterial Infections | 2 | 1988 | 1401 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 1991 | 881 | 0.020 |
Why?
|
| Blood Sedimentation | 1 | 1988 | 231 | 0.020 |
Why?
|
| Aminoglycosides | 1 | 1988 | 162 | 0.020 |
Why?
|
| Blood Pressure | 2 | 1997 | 8551 | 0.020 |
Why?
|
| Psychometrics | 1 | 1996 | 3002 | 0.020 |
Why?
|
| Viruses | 1 | 1991 | 375 | 0.020 |
Why?
|
| Receptors, Virus | 1 | 2010 | 649 | 0.020 |
Why?
|
| Bacteriological Techniques | 2 | 1986 | 277 | 0.020 |
Why?
|
| Microcomputers | 1 | 1987 | 147 | 0.020 |
Why?
|
| Sensitivity and Specificity | 4 | 2011 | 14723 | 0.020 |
Why?
|
| Psychophysiologic Disorders | 1 | 1968 | 228 | 0.020 |
Why?
|
| Diabetes Mellitus | 2 | 1976 | 5749 | 0.020 |
Why?
|
| Genome, Viral | 1 | 2010 | 667 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2002 | 9957 | 0.020 |
Why?
|
| Odds Ratio | 1 | 1998 | 9849 | 0.020 |
Why?
|
| Social Adjustment | 1 | 1968 | 631 | 0.020 |
Why?
|
| Lymphatic Diseases | 1 | 1987 | 323 | 0.020 |
Why?
|
| Base Sequence | 3 | 2010 | 12797 | 0.020 |
Why?
|
| Heart Rate | 1 | 1997 | 4091 | 0.020 |
Why?
|
| Neutrophils | 1 | 1998 | 3721 | 0.020 |
Why?
|
| Dermatitis | 1 | 1987 | 199 | 0.020 |
Why?
|
| Age Factors | 4 | 1999 | 18373 | 0.020 |
Why?
|
| Student Health Services | 2 | 1976 | 41 | 0.020 |
Why?
|
| Follow-Up Studies | 3 | 1996 | 39052 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2003 | 12073 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2010 | 1252 | 0.020 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1993 | 2232 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 1992 | 2715 | 0.020 |
Why?
|
| Plasmids | 1 | 2010 | 2308 | 0.020 |
Why?
|
| Technetium Tc 99m Exametazime | 2 | 1994 | 68 | 0.020 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 1997 | 2104 | 0.020 |
Why?
|
| Hospitals | 1 | 1978 | 3954 | 0.020 |
Why?
|
| Prospective Payment System | 1 | 1985 | 133 | 0.020 |
Why?
|
| RNA, Viral | 1 | 2013 | 2901 | 0.020 |
Why?
|
| Swine | 1 | 1994 | 5918 | 0.010 |
Why?
|
| Organotechnetium Compounds | 2 | 1994 | 137 | 0.010 |
Why?
|
| Molecular Sequence Data | 3 | 2010 | 18111 | 0.010 |
Why?
|
| Mycoplasma pneumoniae | 1 | 1983 | 43 | 0.010 |
Why?
|
| Hospital Administration | 1 | 1988 | 353 | 0.010 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 1987 | 547 | 0.010 |
Why?
|
| Viral Load | 1 | 2013 | 3300 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4751 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2009 | 1115 | 0.010 |
Why?
|
| Mycoplasma Infections | 1 | 1983 | 118 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2010 | 2649 | 0.010 |
Why?
|
| Budgets | 1 | 1985 | 229 | 0.010 |
Why?
|
| Public Health | 1 | 2016 | 2602 | 0.010 |
Why?
|
| Hospitals, General | 1 | 1988 | 749 | 0.010 |
Why?
|
| Streptococcus pyogenes | 1 | 1986 | 289 | 0.010 |
Why?
|
| Pandemics | 1 | 2023 | 8386 | 0.010 |
Why?
|
| Drug Interactions | 1 | 1988 | 1460 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2004 | 17445 | 0.010 |
Why?
|
| Young Adult | 3 | 2017 | 56434 | 0.010 |
Why?
|
| Administration, Topical | 1 | 1984 | 690 | 0.010 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2010 | 1320 | 0.010 |
Why?
|
| Casts, Surgical | 1 | 1984 | 178 | 0.010 |
Why?
|
| Clinical Trials as Topic | 2 | 1990 | 7914 | 0.010 |
Why?
|
| Oximes | 2 | 1994 | 311 | 0.010 |
Why?
|
| Autoantibodies | 1 | 1991 | 2036 | 0.010 |
Why?
|
| Phenotype | 2 | 2018 | 16367 | 0.010 |
Why?
|
| Mental Health | 1 | 1996 | 3014 | 0.010 |
Why?
|
| Bandages | 1 | 1984 | 266 | 0.010 |
Why?
|
| Fellowships and Scholarships | 1 | 1990 | 1078 | 0.010 |
Why?
|
| Stroke | 1 | 2004 | 9981 | 0.010 |
Why?
|
| Antibodies, Heterophile | 1 | 1982 | 126 | 0.010 |
Why?
|
| Duodenal Ulcer | 1 | 1982 | 125 | 0.010 |
Why?
|
| Wounds and Injuries | 1 | 1994 | 2400 | 0.010 |
Why?
|
| Stomach Ulcer | 1 | 1982 | 125 | 0.010 |
Why?
|
| Erythrocyte Transfusion | 1 | 1986 | 565 | 0.010 |
Why?
|
| Legionella | 1 | 1981 | 30 | 0.010 |
Why?
|
| Legionnaires' Disease | 1 | 1981 | 48 | 0.010 |
Why?
|
| Dermatologic Agents | 1 | 1984 | 278 | 0.010 |
Why?
|
| Digestive System | 1 | 1982 | 253 | 0.010 |
Why?
|
| Cohort Studies | 3 | 2013 | 40558 | 0.010 |
Why?
|
| Urethra | 1 | 1982 | 408 | 0.010 |
Why?
|
| Cystitis | 1 | 1980 | 93 | 0.010 |
Why?
|
| Syphilis | 1 | 1982 | 227 | 0.010 |
Why?
|
| Bacteriuria | 1 | 1980 | 102 | 0.010 |
Why?
|
| California | 3 | 1987 | 1402 | 0.010 |
Why?
|
| Urologic Diseases | 2 | 1987 | 244 | 0.010 |
Why?
|
| Rhode Island | 1 | 1980 | 347 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2010 | 4328 | 0.010 |
Why?
|
| Homosexuality | 1 | 1980 | 262 | 0.010 |
Why?
|
| Medical Records | 2 | 1976 | 1413 | 0.010 |
Why?
|
| Diagnostic Errors | 2 | 1999 | 1257 | 0.010 |
Why?
|
| Hospital Bed Capacity, 300 to 499 | 1 | 1979 | 60 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1996 | 9274 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2017 | 12720 | 0.010 |
Why?
|
| Bone and Bones | 1 | 1990 | 2576 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 1993 | 7785 | 0.010 |
Why?
|
| Cytopathogenic Effect, Viral | 1 | 1998 | 156 | 0.010 |
Why?
|
| Cough | 1 | 1982 | 555 | 0.010 |
Why?
|
| Virus Cultivation | 1 | 1998 | 92 | 0.010 |
Why?
|
| Lip | 1 | 2000 | 195 | 0.010 |
Why?
|
| Education, Medical, Graduate | 1 | 1990 | 2291 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1979 | 424 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 1995 | 9647 | 0.010 |
Why?
|
| Immunoassay | 1 | 2002 | 752 | 0.010 |
Why?
|
| Physician's Role | 1 | 1985 | 943 | 0.010 |
Why?
|
| Rheumatic Fever | 1 | 1978 | 71 | 0.010 |
Why?
|
| Neisseria gonorrhoeae | 1 | 1980 | 238 | 0.010 |
Why?
|
| Software Design | 1 | 1998 | 176 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 1979 | 694 | 0.010 |
Why?
|
| Depression | 1 | 1997 | 7766 | 0.010 |
Why?
|
| Reproducibility of Results | 2 | 2011 | 19905 | 0.010 |
Why?
|
| Sexually Transmitted Diseases | 2 | 1980 | 623 | 0.010 |
Why?
|
| Multivariate Analysis | 3 | 1997 | 12244 | 0.010 |
Why?
|
| Aged, 80 and over | 4 | 2010 | 57776 | 0.010 |
Why?
|
| Medical Records, Problem-Oriented | 1 | 1976 | 35 | 0.010 |
Why?
|
| Joint Instability | 1 | 1984 | 792 | 0.010 |
Why?
|
| Computer Systems | 1 | 1997 | 483 | 0.010 |
Why?
|
| Genital Diseases, Male | 1 | 1976 | 84 | 0.010 |
Why?
|
| Sulfisoxazole | 1 | 1975 | 8 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1996 | 429 | 0.010 |
Why?
|
| Data Collection | 1 | 1985 | 3339 | 0.010 |
Why?
|
| Neuropsychological Tests | 2 | 2001 | 6994 | 0.010 |
Why?
|
| Legislation, Medical | 1 | 1976 | 100 | 0.010 |
Why?
|
| Nursing Assessment | 1 | 1975 | 107 | 0.010 |
Why?
|
| Electronystagmography | 1 | 1995 | 24 | 0.010 |
Why?
|
| Erythema Infectiosum | 1 | 1995 | 15 | 0.010 |
Why?
|
| Ampicillin | 1 | 1975 | 139 | 0.010 |
Why?
|
| Nystagmus, Optokinetic | 1 | 1995 | 31 | 0.010 |
Why?
|
| Suppositories | 1 | 1974 | 15 | 0.010 |
Why?
|
| Otolithic Membrane | 1 | 1995 | 38 | 0.010 |
Why?
|
| Trichomonas Infections | 1 | 1975 | 43 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 1979 | 2031 | 0.010 |
Why?
|
| Electrooculography | 1 | 1995 | 118 | 0.010 |
Why?
|
| Acute Kidney Injury | 1 | 1988 | 1968 | 0.010 |
Why?
|
| Bartonella Infections | 1 | 1994 | 22 | 0.010 |
Why?
|
| Tetracycline | 1 | 1975 | 214 | 0.010 |
Why?
|
| Multiphasic Screening | 1 | 1974 | 6 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1998 | 2646 | 0.010 |
Why?
|
| Drug Evaluation | 1 | 1976 | 647 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 1987 | 3589 | 0.010 |
Why?
|
| Penicillins | 1 | 1977 | 380 | 0.010 |
Why?
|
| School Nursing | 1 | 1974 | 31 | 0.010 |
Why?
|
| Morphogenesis | 1 | 1998 | 752 | 0.010 |
Why?
|
| Isoenzymes | 1 | 1979 | 1728 | 0.010 |
Why?
|
| Reflex, Vestibulo-Ocular | 1 | 1995 | 85 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 1984 | 6489 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1998 | 2505 | 0.010 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 1 | 1974 | 89 | 0.010 |
Why?
|
| Hearing Tests | 1 | 1974 | 122 | 0.010 |
Why?
|
| Methods | 1 | 1974 | 1129 | 0.010 |
Why?
|
| Vision Tests | 1 | 1974 | 167 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 1995 | 1095 | 0.010 |
Why?
|
| Medical Staff, Hospital | 1 | 1997 | 601 | 0.010 |
Why?
|
| Sepsis | 1 | 1987 | 2593 | 0.010 |
Why?
|
| Pediatric Nursing | 1 | 1974 | 103 | 0.010 |
Why?
|
| False Negative Reactions | 1 | 1974 | 588 | 0.010 |
Why?
|
| Mast Cells | 1 | 2000 | 1544 | 0.010 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 1996 | 657 | 0.010 |
Why?
|
| Erythrocytes | 1 | 1982 | 2455 | 0.010 |
Why?
|
| Heart Failure | 1 | 1996 | 10895 | 0.010 |
Why?
|
| Stomach Neoplasms | 1 | 1982 | 1332 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1992 | 803 | 0.010 |
Why?
|
| Recurrence | 1 | 1984 | 8340 | 0.010 |
Why?
|
| Endoscopy | 1 | 1982 | 1787 | 0.010 |
Why?
|
| Health Facility Planning | 1 | 1971 | 19 | 0.010 |
Why?
|
| Internship and Residency | 2 | 1989 | 5789 | 0.010 |
Why?
|
| DNA Probes | 1 | 1992 | 560 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1992 | 1085 | 0.010 |
Why?
|
| Eye Movements | 1 | 1995 | 507 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1992 | 708 | 0.010 |
Why?
|
| Injury Severity Score | 1 | 1994 | 1014 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 1997 | 2971 | 0.010 |
Why?
|
| Heart Function Tests | 1 | 1992 | 328 | 0.010 |
Why?
|
| User-Computer Interface | 1 | 1998 | 1431 | 0.010 |
Why?
|
| Motion Perception | 1 | 1995 | 408 | 0.010 |
Why?
|
| Child, Preschool | 3 | 1995 | 41005 | 0.010 |
Why?
|
| Sexual Behavior | 1 | 1980 | 2055 | 0.010 |
Why?
|
| Rabbits | 1 | 1996 | 4894 | 0.010 |
Why?
|
| Vagina | 1 | 1975 | 825 | 0.010 |
Why?
|
| Ancillary Services, Hospital | 1 | 1989 | 23 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 1994 | 35424 | 0.000 |
Why?
|
| Reference Values | 1 | 1995 | 4982 | 0.000 |
Why?
|
| Health Care Costs | 1 | 2001 | 3209 | 0.000 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1992 | 2839 | 0.000 |
Why?
|
| Hospital Costs | 1 | 1994 | 985 | 0.000 |
Why?
|
| Mice, Inbred BALB C | 1 | 1996 | 6387 | 0.000 |
Why?
|
| Lymphocyte Activation | 1 | 1998 | 5524 | 0.000 |
Why?
|
| Patient Admission | 1 | 1994 | 1380 | 0.000 |
Why?
|
| Cloning, Molecular | 1 | 1992 | 4320 | 0.000 |
Why?
|
| Bone Marrow Transplantation | 1 | 1995 | 2765 | 0.000 |
Why?
|
| Memory | 1 | 1996 | 2174 | 0.000 |
Why?
|
| Patient Education as Topic | 1 | 1976 | 2278 | 0.000 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 1996 | 6038 | 0.000 |
Why?
|
| Anemia, Sickle Cell | 1 | 1974 | 1020 | 0.000 |
Why?
|
| Electrocardiography | 1 | 1979 | 6442 | 0.000 |
Why?
|
| Specialization | 1 | 1990 | 776 | 0.000 |
Why?
|
| Developing Countries | 1 | 1978 | 2815 | 0.000 |
Why?
|
| Anemia | 1 | 1974 | 1503 | 0.000 |
Why?
|
| Poverty | 1 | 1976 | 2660 | 0.000 |
Why?
|
| Drug Resistance, Microbial | 1 | 1987 | 862 | 0.000 |
Why?
|
| Patient Care Team | 1 | 1974 | 2531 | 0.000 |
Why?
|
| Child Development | 1 | 1974 | 2223 | 0.000 |
Why?
|
| Proportional Hazards Models | 1 | 1997 | 12356 | 0.000 |
Why?
|
| Patient Acceptance of Health Care | 1 | 1975 | 3020 | 0.000 |
Why?
|
| Hygiene | 1 | 1982 | 97 | 0.000 |
Why?
|
| Lymphocytosis | 1 | 1982 | 119 | 0.000 |
Why?
|
| Microbial Sensitivity Tests | 1 | 1987 | 1877 | 0.000 |
Why?
|
| Quality of Life | 1 | 1982 | 12803 | 0.000 |
Why?
|
| Cross-Sectional Studies | 1 | 2002 | 25041 | 0.000 |
Why?
|
| Disease Susceptibility | 1 | 1987 | 1782 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1992 | 13814 | 0.000 |
Why?
|
| Urban Population | 1 | 1968 | 2022 | 0.000 |
Why?
|
| Maine | 1 | 1979 | 139 | 0.000 |
Why?
|
| Analysis of Variance | 1 | 1968 | 6366 | 0.000 |
Why?
|
| Genetic Variation | 1 | 1995 | 6542 | 0.000 |
Why?
|
| Mortality | 1 | 1989 | 2864 | 0.000 |
Why?
|
| Curriculum | 1 | 1990 | 3605 | 0.000 |
Why?
|
| Vaginal Smears | 1 | 1979 | 511 | 0.000 |
Why?
|
| Physicians, Family | 1 | 1978 | 345 | 0.000 |
Why?
|
| Efficiency | 1 | 1978 | 462 | 0.000 |
Why?
|
| Severity of Illness Index | 1 | 1992 | 15535 | 0.000 |
Why?
|
| Intensive Care Units | 1 | 1988 | 3680 | 0.000 |
Why?
|
| Escherichia coli | 1 | 1987 | 4217 | 0.000 |
Why?
|
| Mutation | 1 | 1999 | 29786 | 0.000 |
Why?
|
| Algorithms | 1 | 1994 | 13882 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1974 | 25628 | 0.000 |
Why?
|
| Health Services | 1 | 1978 | 758 | 0.000 |
Why?
|
| Abdomen | 1 | 1978 | 1118 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 1997 | 63115 | 0.000 |
Why?
|
| HIV Infections | 1 | 1995 | 16715 | 0.000 |
Why?
|
| Retrospective Studies | 2 | 1987 | 77459 | 0.000 |
Why?
|